FIELD: pharmaceutics.
SUBSTANCE: invention relates to the field of pharmacy and concerns the creation of a pharmaceutical composition in the form of a capsule based on lornoxicam. The pharmaceutical composition, which has an anti-inflammatory effect, contains lornoxicam, solid fat, poloxamer 188 and twin-80 in the declared quantities.
EFFECT: invention provides an expansion of the arsenal of anti-inflammatory drugs.
1 cl, 1dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
THE METHOD OF OBTAINING A PHARMACEUTICAL COMPOSITION WITH TACROLIMUS (VARIANTS) AND A PHARMACEUTICAL COMPOSITION OBTAINED BY THESE METHODS | 2022 |
|
RU2792098C1 |
NEW SELF-EMULSIFYING SYSTEM FOR DELIVERY OF DRUGS | 2001 |
|
RU2270675C9 |
NEW SELF-EMULSIFIED DRUG DELIVERY SYSTEM | 2001 |
|
RU2275908C2 |
METHOD OF PREPARING PHARMACEUTICAL PRODUCT | 2018 |
|
RU2796022C2 |
PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY, CARDIO- AND CHONDROPROTECTIVE ACTIVITY, ACTION PREVENTING GASTROPATHIES CAUSED BY NSAID, AND METHOD FOR PREPARING IT | 2011 |
|
RU2502507C2 |
PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
RECTAL SUPPOSITORIES, HAVING ANTI-INFLAMMATORY, ANTIOXIDANT, IMMUNOSTIMULATING ACTION, CONTAINING RHIZOMES WITH COMMON TURMERIC ROOTS | 2020 |
|
RU2743427C1 |
NEW APPLICATION OF POLOXAMER AS A PHARMACOLOGICALLY ACTIVE SUBSTANCE | 2018 |
|
RU2760324C1 |
PHARMACEUTICAL COMPOSITION OF NITROXY DERIVATIVE NONSTEROID ANTI-INFLAMMATORY DRUGS | 2006 |
|
RU2406482C2 |
METHOD FOR INCREASING THE LEVEL OF HEMOGLOBIN IN THE BLOOD IN A PATIENT WITH CANCER | 2019 |
|
RU2773153C1 |
Authors
Dates
2021-08-03—Published
2020-12-14—Filed